| Bioactivity | ABHD antagonist 1 possesses ABHD6 (α/β-Hydrolase domain containing 6) inhibitory activity, involving the regulation of biochemical pathways involved in ABHD6, thereby affecting cell function and inflammatory response. ABHD antagonist 1 can be used in pain, neuropathic diseases, inflammatory diseases. Autoimmune diseases, metabolic diseases, and cancer research[1]. |
| CAS | 3034510-10-3 |
| Formula | C19H20BrN3O3S |
| Molar Mass | 450.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. 篤史 吉田, et al. Abhd6 antagonist.WO2024071398A1.2023-09-29 |